Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
J0301750	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2004-01-15	Aventis Pharma Deutschland GmbH,	Aventis Pharma Deutschland GmbH	Certificate Issued	2004-09-21	view
J0400203	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2004-02-29	Aventis Pharma Deutschland GmbH,	Aventis Pharma Deutschland GmbH	Certificate Issued	2004-08-23	view
J0400204	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2004-02-29	Aventis Pharma Deutschland GmbH,	Aventis Pharma Deutschland GmbH	Certificate Issued	2004-08-23	view
JYSB0500053	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2005-07-13	Aventis Pharma Deutschland GmbH,	Aventis Pharma Deutschland GmbH	Certificate Issued	2005-11-17	view
JYSB0500059	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2005-07-25	Aventis Pharma Deutschland GmbH,	Aventis Pharma Deutschland GmbH	Certificate Completed-Pending Issued	2006-05-30	view
JYHB0500582	雷米普利片	ramipril	Tablet	Chemical Drugs	Supplementary Application	2005-09-01	Aventis Pharma Deutschland GmbH	Aventis Pharma Deutschland GmbH	Certificate Issued	2005-12-30	view